JERUSALEM—New research conducted at the Cleveland Clinic Foundation confirmed the clinical benefits of continuous waveform CO2 monitoring using Oridion Systems Ltd.’s Oridion Microstream® capnography to reduce the incidence of hypoxemia, severe hypoxemia, and apnea in procedural sedation. The benefits persisted even after oxygen supplementation.
The aim of the study was to examine whether intervention, based on information from capnography monitoring of patients under sedation for gastrointestinal endoscopy procedures, could reduce the frequency of hypoxemia and apnea. The study analyzed a total of 247 patients undergoing ERCP and EUS procedures in a randomized, double-blinded design using the Oridion Smart CapnoBloc™ ventilation management system (CO2 sampling incorporated into a bite block) and the Capnostream™20 dual parameter monitor.
The authors concluded that capnography monitoring functions as an early warning system for hypoxemia and may further improve patient safety during gastrointestinal endoscopy.